Tag: Health
28 predictions tagged with "Health".
The First In Vivo CRISPR-Cas9 Gene Editing Therapy, Lonvoguran Ziclumeran (Lonvo-z), Is Expected To Receive US FDA Approval In 2027 For Hereditary Angioedema.2027 · Health
AI-driven Drug Discovery Platforms Are Expected To Bring Their First Commercial Products To Market.2027 · Health
Gene Therapies Are Expected To Gain Widespread Approval For Rare Diseases And Enter Clinical Use.2027 · Health
Personalized MRNA Cancer Vaccines Are Expected To Show Promising Phase 3 Trial Results.2027 · Health
Moderna And Merck's Personalized MRNA Neoantigen Cancer Vaccine Intismeran Autogene (V940/mRNA-4157) Is Expected To Receive Its First Regulatory Approval In 2028 As Adjuvant Treatment For High-risk Melanoma.2028 · Health
AI-assisted Diagnostic Systems Are Expected To Reach Clinician-level Accuracy In Radiology And Pathology.2028 · Health
Genomics-based Personalized Medicine Is Expected To Become Standard Of Care In Oncology.2028 · Health
3D Bioprinters Are Expected To Enter Clinical Use For Organ Transplantation.2028 · Health
The Personalized MRNA Cancer Vaccine From Moderna And Merck (Intismeran Combined With Keytruda) Will Receive Its First Approval From A Major Regulator (FDA Or EMA).2029 · Health
AI Diagnostic Systems Are Expected To Surpass Clinician-level Accuracy Across All Medical Imaging.2029 · Health
Bioprinters Are Expected To Be Able To Produce Fully Functional Organs.2029 · Health
Gene Therapies Are Expected To Start Being Used In Common Diseases Such As Cancer And Heart Disease.2029 · Health
A Genetically Edited Pig Kidney (Xenotransplant) Is Expected To Receive Its First Regulatory Approval By 2030 For End-stage Kidney Disease.2030 · Health
AI Diagnostic Systems Are Expected To Surpass Clinician-level Accuracy Across All Medical Fields.2030 · Health
Bioprinters Are Likely To Produce Fully Functional Organs And Eliminate Transplant Waitlists.2030 · Health
Gene Therapies Are Likely To Reach A Level Where They Can Treat All Genetic Diseases.2030 · Health
The First Gene Therapy Developed With Base-editing Technology Will Receive Regulatory Approval For Sickle Cell Disease Or Beta Thalassemia.2032 · Health
Continuous Glucose/cholesterol Monitoring With Biosensors Will Become Widespread.2033 · Health
Widespread Adoption Of AI-assisted Mental Health Therapies2033 · Health
AI Use In Early Diagnosis Of Neurodegenerative Diseases Will Become Widespread.2033 · Health
Personalized MRNA Cancer Vaccines Will Gain Approval Or Enter Standard Adjuvant Care In At Least Two Cancer Types Beyond Melanoma (Lung And Pancreatic).2035 · Health
AI Diagnostic Systems Are Expected To Far Surpass Clinician-level Accuracy Across All Medical Fields.2035 · Health
Bioprinting Of Fully Functional Organs Ending Transplant Waitlists Is Expected Only With Low Probability.2035 · Health
Gene Therapies Becoming A Standard Capable Of Treating All Diseases Is Expected Only With Low Probability.2035 · Health
AI-assisted Diagnostic Systems Reach Physician-level Performance Across All Medical Imaging2035 · Health
Whole-genome Sequencing Will Cost Under $100.2035 · Health
Aging Biomarkers Will Be Routinely Used In Standard Health Screenings By 2035.2035 · Health
Telehealth Services Will Account For 40% Of All Healthcare Services2035 · Health
